Form 13-F position report

BIOCEPT INC

Reported by MORGAN STANLEY

Company profile Manager portfolio Source filing
BIOC CUSIP 09072V501 Manager CIK 0000895421
Latest reported change

First reported at 6 shares this quarter.

New
% of reported 13F value 0 This manager · Q3 2022
Shares 6 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 9 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q4 2022 Reduced 0 -6 (-100.0%) 0 $0 2023-02-14
Q3 2022 New 6 +6 (0.0%) 0 $0 2022-11-14
Q2 2022 Reduced 0 -1,900 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 1,900 +80 (4.4%) < 0.01% $4,000 2022-05-13
Q4 2021 Reduced 1,820 -7,046 (-79.5%) < 0.01% $6,000 2022-02-14
Q3 2021 Reduced 8,866 -169,059 (-95.0%) < 0.01% $35,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

33 managers reported BIOCEPT INC for Q3 2022.

Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 617,610 -38,064 < 0.01% $569,000 9 qtrs
GLOBEFLEX CAPITAL L P Unchanged 233,578 0 0.04% $215,000 5 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 168,400 -7,100 < 0.01% $155,000 5 qtrs
BlackRock Inc Unchanged 157,913 0 < 0.01% $145,000 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 137,872 0 < 0.01% $127,000 9 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 109,436 0 < 0.01% $101,000 3 qtrs
STATE STREET CORPORATION Unchanged 40,596 0 < 0.01% $37,000 6 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 37,018 -66,106 < 0.01% $34,000 2 qtrs
SABBY MANAGEMENT LLC Unchanged 30,502 0 0.04% $28,000 8 qtrs
NORTHERN TRUST CORPORATION Unchanged 26,818 0 < 0.01% $25,000 9 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
November 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
6
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.